Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gastric mucosal protective and reparative pathways represent a complex physiological system designed to maintain the integrity of the stomach lining against aggressive factors like gastric acid, pepsin, and ingested irritants (Wallace, 2008, Physiol Rev). This system operates through multiple levels of defense, including the pre-epithelial mucus-bicarbonate barrier, the epithelial cell layer capable of rapid restitution and proliferation, and a robust sub-epithelial microcirculation (Laine et al., 2008, Gastroenterology). Key molecular mediators in these pathways include prostaglandins (particularly PGE2 and PGI2), which stimulate mucus secretion and blood flow, and growth factors such as epidermal growth factor (EGF) and trefoil factor family (TFF) peptides that facilitate tissue repair (Tarnawski & Ahluwalia, 2012, Curr Med Chem). In disease states like peptic ulcer disease or NSAID-induced gastropathy, these protective mechanisms are overwhelmed or impaired (StatPearls, 2023). Therapeutic intervention often involves cytoprotective agents that mimic or stimulate these endogenous pathways to enhance healing and prevent mucosal injury (PubChem, 2024). These drugs, such as misoprostol or rebamipide, work by increasing mucus production, improving blood flow, and accelerating the repair of damaged tissue.
Enhancement of endogenous defense mechanisms including mucus and bicarbonate secretion, mucosal blood flow, and epithelial cell renewal.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastric mucosal protective and reparative pathways.